iTonic Holdings (ITOC) Stock Overview
A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ITOC Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
iTonic Holdings Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.41 |
| 52 Week High | US$32.00 |
| 52 Week Low | US$0.32 |
| Beta | 0 |
| 1 Month Change | -32.18% |
| 3 Month Change | -31.17% |
| 1 Year Change | -84.30% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -89.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| ITOC | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 5.6% | -7.2% | -1.3% |
| 1Y | -84.3% | -42.4% | 10.9% |
Return vs Industry: ITOC underperformed the US Healthcare Services industry which returned -42.4% over the past year.
Return vs Market: ITOC underperformed the US Market which returned 10.9% over the past year.
Price Volatility
| ITOC volatility | |
|---|---|
| ITOC Average Weekly Movement | 33.6% |
| Healthcare Services Industry Average Movement | 8.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ITOC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ITOC's weekly volatility has increased from 28% to 34% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 10 | Jianfei Zhang | www.ftzy.com.cn |
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.
iTonic Holdings Ltd. Fundamentals Summary
| ITOC fundamental statistics | |
|---|---|
| Market cap | US$7.04m |
| Earnings (TTM) | -US$2.41m |
| Revenue (TTM) | US$305.22k |
Is ITOC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ITOC income statement (TTM) | |
|---|---|
| Revenue | US$305.22k |
| Cost of Revenue | US$52.32k |
| Gross Profit | US$252.89k |
| Other Expenses | US$2.67m |
| Earnings | -US$2.41m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 82.86% |
| Net Profit Margin | -790.57% |
| Debt/Equity Ratio | 2.9% |
How did ITOC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/16 03:38 |
| End of Day Share Price | 2026/02/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iTonic Holdings Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.